Heart failure highlights in 2012-2013Liu, L. C. Y., Damman, K., Lipsic, E., Maass, A. H., Rienstra, M. & Westenbrink, B. D., Feb-2014, In : European Journal of Heart Failure. 16, 2, p. 122-132 11 p.
Research output: Contribution to journal › Review article › Academic › peer-review
Heart failure has become the cardiovascular epidemic of the century. The European Journal of Heart Failure is dedicated to the advancement of knowledge in the field of heart failure management. In 2012 and 2013, several pioneering scientific discoveries and paradigm-shifting clinical trials have been published. In the current paper, we will discuss the most significant novel insights into the pathophysiology, diagnosis, and treatment of heart failure that were published during this period. All relevant research areas are discussed, including pathophysiology, co-morbidities, arrhythmias, biomarkers, clinical trials, and device therapy, including left ventricular assist devices.
|Number of pages||11|
|Journal||European Journal of Heart Failure|
|Publication status||Published - Feb-2014|
- Heart failure, Highlights 2012/13, Pathophysiology, Co-morbidities, Atrial fibrillation, Biomarkers, Pharmacological therapy, Interventional treatment, CRT, Assist devices, CARDIAC-RESYNCHRONIZATION THERAPY, PRESERVED EJECTION FRACTION, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, LEFT-VENTRICULAR DYSFUNCTION, MINERALOCORTICOID RECEPTOR ANTAGONIST, MECHANICAL CIRCULATORY SUPPORT, RANDOMIZED CONTROLLED-TRIAL, DIRECT RENIN INHIBITION, CHRONIC KIDNEY-DISEASE, ASSIST DEVICE SUPPORT